Filing Details

Accession Number:
0001140361-14-045854
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-19 11:32:33
Reporting Period:
2014-12-17
Filing Date:
2014-12-19
Accepted Time:
2014-12-19 11:32:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380177 Ronald Richard 2273 Research Blvd
Suite 400
Rockville MD 20850
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-17 5,000 $2.74 24,100 No 4 M Direct
Common Stock Disposition 2014-12-17 5,000 $27.00 19,100 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2014-12-17 5,000 $0.00 5,000 $2.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2006-01-26 2015-01-26 No 4 M Direct
Footnotes
  1. Consists of an option granted under the company's stock incentive plan on January 26, 2005.
  2. The option vested in three equal installments in January 2006, 2007 and 2008.